Incidence of trisomy 8 and 9, deletion of D13s319 and 020S108 loci and BCR/ABL translocation in non-treated essential thrombocythemia patients: An analysis of bone marrow cells using interphase fluorescence in situ hybridization

Haematologica

Volumn 88, Issue 1, 2003, Pages 110-111

  Zamora, Lurdes ^a,b   Espinet, Blanca ^a,b   Florensa, Lourdes ^b   Besses, Carles ^b   Salido, Marta ^a   Sole, Francesc ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Conventional cytogenetics; Essential thrombocythemia; FISH

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; BONE MARROW CELL; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; INCIDENCE; INTERMETHOD COMPARISON; INTERPHASE; THROMBOCYTHEMIA; TRISOMY; TRISOMY 8; TRISOMY 9;

BONE MARROW EXAMINATION; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; THROMBOCYTHEMIA, HEMORRHAGIC; TRANSLOCATION, GENETIC; TRISOMY;

EID: 0037310692     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bench AJ, Nacheva EP, Champion KM, Green AR. Molecular genetics and cytogenetics of myeloproliferative disorders. Baillières Clin Haematol 1998;11:819-48.
2. Anonymous. Report on essential thrombocythemia. Cancer Genet Cytogenet 1981;4:138-42.
3. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997;34:29-39.
4. ISCN. Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. F Mitelman, editor. Basel: S. Karger;1995.
5. Elis A, Amiel A, Manor Y, Tangi I, Fejgin M, Lishner M. The detection of trisomies 8 and 9 in patients with essential thrombocytosis by fluorescence in situ hybridization. Cancer Genet Cytogenet 1996;92:14-7.
6. Swolin B, Safai-Kutti S, Anghem E, Kutti J. No increased frequency of trisomies 8 and 9 by fluorescence in situ hybridization in untreated patients with essential thrombocythemia. Cancer Genet Cytogenet 2001;126:56-9.
7. Bench AJ, Cross NC, Huntly BJ, Nacheva EP, Green AR. Myeloproliferative disorders. Best Pract Res Clin Haematol 2001;14:531-51.
8. Corradini P, Palumbo AP, Battaglio S, Ponzio G, Boccadoro M, Pileri A. Analysis of the breakpoint cluster region in essential thrombocythemia. Haematologica 1990;75:573-5.
9. Solé F, Florensa L, Espinet B, Besses C, Lloveras E, Woessner S. Absence of bcr/abl rearrangement in 41 patients with essential thrombocythemia. Haematologica 2000;85:215-6.